LC–MS-based metabolomics assists with quality assessment and traceability of wild and cultivated plants of Sutherlandia frutescens (Fabaceae)

[1]  M. Venter,et al.  Effect of Sutherlandia frutescens on the Lipid Metabolism in an Insulin Resistant Rat Model and 3T3‐L1 Adipocytes , 2012, Phytotherapy research : PTR.

[2]  A. Viljoen,et al.  Quantitative variation of amino acids in Sutherlandia frutescens (Cancer bush)—towards setting parameters for quality control , 2012 .

[3]  H. M. Heyman,et al.  NMR-based metabolomics as a quality control tool for herbal products , 2012 .

[4]  A. Joubert,et al.  Differential signaling involved in Sutherlandia frutescens-induced cell death in MCF-7 and MCF-12A cells. , 2012, Journal of ethnopharmacology.

[5]  A. Joubert,et al.  The apoptosis inducing effects of Sutherlandia spp. extracts on an oesophageal cancer cell line. , 2011, Journal of ethnopharmacology.

[6]  M. Moyo,et al.  Plant biotechnology in South Africa: Micropropagation research endeavours, prospects and challenges , 2011 .

[7]  B. Wyk.  The potential of South African plants in the development of new medicinal products , 2011 .

[8]  A. Nicholas,et al.  HPLC and GC analyses of in vitro-grown leaves of the cancer bush Lessertia (Sutherlandia) frutescens L. reveal higher yields of bioactive compounds , 2011, Plant Cell, Tissue and Organ Culture (PCTOC).

[9]  M. Stander,et al.  Nitrogen supply and abiotic stress influence canavanine synthesis and the productivity of in vitro regenerated Sutherlandia frutescens microshoots. , 2010, Journal of plant physiology.

[10]  W. Folk,et al.  Quantitative determination of flavonoids and cycloartanol glycosides from aerial parts of Sutherlandia frutescens (L.) R. BR. by using LC-UV/ELSD methods and confirmation by using LC-MS method. , 2010, Journal of pharmaceutical and biomedical analysis.

[11]  A. Nicholas,et al.  Micropropagation and bioreactor studies of the medicinally important plant Lessertia (Sutherlandia) frutescens L. , 2010 .

[12]  W. Folk,et al.  Flavonol glycosides from the south African medicinal plant Sutherlandia frutescens. , 2010, Planta medica.

[13]  M. van de Venter,et al.  Sutherlandia frutescens limits the development of insulin resistance by decreasing plasma free fatty acid levels , 2009, Phytotherapy research : PTR.

[14]  F. R. Heerden,et al.  SU3, an oxocycloartane diglucoside from Sutherlandia humilis , 2009 .

[15]  M. Lottering,et al.  In vitro effects of Sutherlandia frutescens water extracts on cell numbers, morphology, cell cycle progression and cell death in a tumorigenic and a non-tumorigenic epithelial breast cell line. , 2009, Journal of ethnopharmacology.

[16]  Y. Choi,et al.  Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. , 2009, Planta medica.

[17]  C. Albrecht,et al.  A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). , 2008, Journal of ethnopharmacology.

[18]  A. Nicholas,et al.  Influences of pre-sowing seed treatments on germination of the cancer bush (Sutherlandia frutescens), a reputed medicinal plant in arid environments , 2008 .

[19]  James Syce,et al.  Cycloartane glycosides from Sutherlandia frutescens. , 2008, Journal of natural products.

[20]  R. Verpoorte,et al.  Metabolomic quality control of claimed anti-malarial Artemisia afra herbal remedy and A. afra and A. annua plant extracts , 2008 .

[21]  F. Joubert,et al.  Influence of Sutherlandia frutescens extracts on cell numbers, morphology and gene expression in MCF-7 cells. , 2007, Journal of ethnopharmacology.

[22]  W. Chadwick,et al.  Anti-diabetic effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet. , 2007, Journal of ethnopharmacology.

[23]  N. Makunga,et al.  Medicinal Plants and Biotechnology: An integrated approach to healthcare , 2006 .

[24]  Kenneth A. Chinkwo,et al.  Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells. , 2005, Journal of ethnopharmacology.

[25]  J. Trygg,et al.  Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. , 2005, Analytical chemistry.

[26]  A. Cromarty,et al.  The antioxidant potential of Sutherlandia frutescens. , 2004, Journal of ethnopharmacology.

[27]  Andrew W. Douglas,et al.  Site-specific variation in the root chemistry and antifungal activity of Caltha leptosepala and Trollius laxus (Ranunculaceae) , 2004 .

[28]  J. Tai,et al.  In vitro culture studies of Sutherlandia frutescens on human tumor cell lines. , 2004, Journal of ethnopharmacology.

[29]  C. H. Bornman,et al.  Medicinal plants at the ethnobotany–biotechnology interface in Africa , 2004 .

[30]  M. Bank,et al.  Lack of genetic differentiation between 19 populations from seven taxa of Sutherlandia Tribe: Galegeae, Fabaceae , 1998 .

[31]  N. Gericke,et al.  Medicinal plants of South Africa , 1998 .

[32]  F. Skoog,et al.  A revised medium for the growth and bioassay with tobacco tissue culture , 1962 .